Page last updated: 2024-10-31

neostigmine and Catatonic Rigidity

neostigmine has been researched along with Catatonic Rigidity in 2 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gurun, MS1
Leinbach, R1
Moore, L1
Lee, CS1
Owen, MD1
Eisenach, JC1
Morgan, M1
Lumley, J1
Gillies, ID1

Other Studies

2 other studies available for neostigmine and Catatonic Rigidity

ArticleYear
Studies on the safety of glucose and paraben-containing neostigmine for intrathecal administration.
    Anesthesia and analgesia, 1997, Volume: 85, Issue:2

    Topics: Analgesia, Epidural; Analgesics; Animals; Cerebrospinal Fluid; Cholinesterase Inhibitors; Dose-Respo

1997
Neuroleptanaesthesia for major surgery. Experience with 500 cases.
    British journal of anaesthesia, 1974, Volume: 46, Issue:4

    Topics: Adolescent; Adult; Age Factors; Aged; Atropine; Blood Pressure; Child; Droperidol; Female; Fentanyl;

1974